SALIVATION IN PARKINSON'S DISEASE

Clinical trials for SALIVATION IN PARKINSON'S DISEASE explained in plain language.

Never miss a new study

Get alerted when new SALIVATION IN PARKINSON'S DISEASE trials appear

Sign up with your email to follow new studies for SALIVATION IN PARKINSON'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for Parkinson's patients struggling with drooling

Symptom relief Completed

This completed study tested whether dihydroergotine mesylate extended-release tablets could safely reduce drooling in people with Parkinson's disease who also have some cognitive impairment. Researchers compared the medication against a placebo in 120 participants over 12 weeks. …

Matched conditions: SALIVATION IN PARKINSON'S DISEASE

Phase: PHASE4 • Sponsor: Second Affiliated Hospital of Soochow University • Aim: Symptom relief

Last updated Mar 30, 2026 14:30 UTC

SALIVATION IN PARKINSON'S DISEASE

Get alerted when new SALIVATION IN PARKINSON'S DISEASE trials appear

New hope for Parkinson's patients struggling with drooling